MDR TB current treatments: A literature review

Satrio Pinayungan 1, * and Nurul Wiqoyah 2

1 Medical Program, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
2 Department of Microbiology, Faculty of Medicine. Universitas Airlangga, Surabaya, Indonesia.
 
Review Article
World Journal of Advanced Research and Reviews, 2023, 20(03), 298–303
Article DOI: 10.30574/wjarr.2023.20.3.2395
 
Publication history: 
Received on 14 October 2023; revised on 20 November 2023; accepted on 23 November 2023
 
Abstract: 
The number of MDR TB cases continues to increase. Various new drugs are being developed to provide effective therapy in handling TB. In-depth understanding is required by clinicians to monitor the progress of therapy for MDR TB. This article aims to explain the pathophysiology of resistance in TB and the pharmacological aspects of the latest antituberculosis drugs in MDR TB.
 
Keywords: 
MDR TB; Drugs; Tuberculosis
 
Full text article in PDF: 
 
Copyright information: 
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0

 

Share this